Stocks
Delcath Systems, Inc.DCTH
NASDAQHealthcareBiotechnology$9.45-0.32%
Focused on liver-directed cancer therapies, the company develops and commercializes systems that deliver high-dose chemotherapy directly to the liver while limiting systemic exposure. Its lead product, the HEPZATO KIT, is used with a proprietary hepatic perfusion system to treat certain metastatic l...
Market Cap: $328.4M52W Range: $8.12 – $18.23
Congressional Interest in Delcath Systems, Inc. (DCTH)
1 member of Congress has disclosed 1 trade in Delcath Systems, Inc. (DCTH), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading DCTH?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-06-09 | Roger W. Marshall | sell | $1K – $15K |